0001493152-20-012533.txt : 20200702
0001493152-20-012533.hdr.sgml : 20200702
20200702170159
ACCESSION NUMBER: 0001493152-20-012533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Angus C.
CENTRAL INDEX KEY: 0001534002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 201010546
MAIL ADDRESS:
STREET 1: C/O INTERMUNE, INC.
STREET 2: 3280 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2020-07-01
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001534002
Russell Angus C.
C/O LINEAGE CELL THERAPEUTICS
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
1
0
0
0
Stock Option (Right to Buy)
0.8263
2020-07-01
4
A
0
40000
0.00
A
2030-07-01
Common Shares
40000
40000
D
Will become exercisable on July 1, 2021, based upon continued service on the board of directors.
/s/ Chase C. Leavitt, as Attorney-in-Fact for Angus C. Russell
2020-07-02